Marché mondial du contrôle des infections – Tendances et prévisions de l’industrie jusqu’en 2031

Analyse et taille du marché du contrôle des infections

Les infections associées aux soins (IAS) sont une cause importante de mortalité dans le monde, tuant près de 100 000 personnes chaque année rien qu'aux États-Unis. Les facteurs contribuant à leur prévalence comprennent l'immunité compromise des patients, des mesures de contrôle des infections inadéquates et la présence de divers agents pathogènes dans les établissements de santé. L'âge et les séjours hospitaliers prolongés aggravent encore le risque. Pour lutter contre ce phénomène, l'accent est de plus en plus mis sur la réduction des infections du site opératoire (ISO) grâce à des protocoles de stérilisation rigoureux. Par conséquent, le marché des produits de stérilisation, essentiels pour la stérilisation des dispositifs médicaux, des produits pharmaceutiques et des sciences de la vie, connaît une croissance significative, contribuant à l'expansion globale du marché du contrôle des infections.

Français La taille du marché mondial du contrôle des infections a été évaluée à 49,10 millions USD en 2023 et devrait atteindre 71,44 millions USD d'ici 2031, avec un TCAC de 4,80 % au cours de la période de prévision de 2024 à 2031. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée du rapport et segmentation du marché       

Market Definition

Viruses, bacteria, fungi, and parasites constitute the primary culprits behind infections, spanning various bodily systems such as the stomach, lungs, eyes, and skin, as well as sexually transmitted routes. This encompasses a spectrum of ailments, including gastrointestinal, respiratory, ocular, aural, hospital-acquired, and dermatological infections. Infection control, therefore, entails the systematic mitigation or eradication of pathogens to curb their dissemination within healthcare environments.

Infection Control Market Dynamics

Drivers

• Escalation in Hospital-Acquired Infections (HAIS) Raise the Demand for Infection Control Products

HAIs pose a significant threat to patient safety and healthcare systems worldwide, leading to increased healthcare costs and patient morbidity and mortality. As healthcare facilities strive to mitigate the risks associated with HAIs, there is a heightened emphasis on implementing robust infection control measures and protocols. This includes stringent sterilization practices, improved hygiene protocols, and the adoption of advanced disinfection technologies to curb the spread of pathogens within healthcare settings. The Centers for Disease Control and Prevention (CDC) reports that approximately 5% of hospitalized patients will acquire a nosocomial infection, also known as a hospital-acquired infection (HAI). These infections contribute to over 99,000 fatalities annually. Consequently, the demand for infection control products and solutions, such as disinfectants, sterilization equipment, and antimicrobial coatings, is witnessing a notable surge, driving market expansion.

• Growing Technological Advancements in Sterilization Equipment Offers Superior Performance

Technological innovations enhance the efficiency, speed, and efficacy of sterilization processes, crucial for mitigating the spread of pathogens in healthcare settings. From the integration of advanced materials to the incorporation of automation and robotics, modern sterilization equipment offers superior performance and reliability. Additionally, developments in low-temperature sterilization methods address the compatibility of sensitive medical devices. The continuous evolution and adoption of such cutting-edge sterilization technologies bolster infection prevention efforts and contribute to the expansion of the global infection control market.

The Ministry of Health and Population's second phase of Infection Control Initiatives in Egypt's nine governorates reflects a commitment to integrating modern sterilization technologies into healthcare facilities. Leveraging advanced equipment and methods, such as automation and low-temperature sterilization, these initiatives aim to enhance hygiene standards, curb infection transmission, and ultimately elevate public health outcomes in the region, aligning with global trends in infection prevention.

Opportunities

• Increasing Outsourcing of Sterilization Services Focuses on Core Operations

Healthcare facilities are opting to outsource sterilization processes to specialized service providers due to factors such as cost-effectiveness, regulatory compliance assurance, and access to advanced sterilization technologies. Outsourcing allows healthcare institutions to focus on core operations while leveraging the expertise and infrastructure of external sterilization service providers. This trend is particularly prominent in regions witnessing a surge in healthcare infrastructure development and stringent regulatory requirements, thereby propelling the demand for infection control solutions and services.

• Escalating Volume of Surgical Procedures Necessitates Stringent Infection Control Measures

Surgical interventions inherently expose patients to heightened infection risks, underscoring the critical need for effective infection control protocols. Healthcare providers are increasingly investing in comprehensive infection control solutions to mitigate the potential for surgical site infections (SSIs) and other healthcare-associated infections (HAIs). This trend is driving the growth of the infection control market, as hospitals and surgical centers prioritize the implementation of advanced sterilization techniques, stringent hygiene protocols, and innovative technologies to safeguard patient health and enhance surgical outcomes.

Restraints/Challenges

• High Implementation Costs Limits the Expansion of Infection Control Standards

The initial capital outlay for acquiring modern equipment and technologies can be prohibitive for many healthcare facilities, particularly those operating on limited budgets or in resource-constrained settings. Ongoing expenses related to maintenance, consumables, and staff training further contribute to the financial burden. This barrier to entry may result in disparities in infection control standards between well-funded institutions and those with fewer resources, potentially compromising public health outcomes.

• Regulatory Compliance Increases the Complexity in Infection Control Procedures

Meeting regulatory compliance often entails extensive testing, documentation, and validation processes, leading to delays in product development and market entry. Varying regulatory frameworks across different regions and countries add complexity and cost to manufacturers seeking global market access. Non-compliance risks penalties, product recalls, and damage to reputation, further impeding market growth.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In May 2020, Getinge AB launched Superfast 20 indicators, enhancing patient safety with faster processing times. These indicators comply with ISO 11138 standards and work with various sterilization methods, augmenting Getinge's global market presence
• In June 2021, Nanosonics launched Nanosonics AuditPro, an innovative digital platform for infection prevention. This product integrates advanced technology to streamline healthcare facilities' infection control processes, promising heightened efficiency and effectiveness
• In August 2021, Advanced Sterilization Products, a Fortive company, launched the STERRAD VELOCITY in the Asia Pacific region. This Biological Indicator/Process Challenge Device enhances sterilization validation, contributing to safer healthcare practices and bolstering ASP's regional market position

Infection Control Market Scope

The market is segmented on the basis of product, application, distribution channel and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Sterilization Products
  • Heat Sterilization Equipment
  • Moist Heat Sterilization Equipment
  • Dry Heat Sterilization Equipment
  • Low-Temperature Sterilization Equipment
  • Radiation Sterilization Equipment
• Cleaning and Disinfection Products
  • Disinfector
  • Washer Disinfector
  • Flusher Disinfector
  • Endoscopic Reprocessor Systems
  • High-End Endoscopic Reprocessor Systems
  • Mid-Range Endoscopic Reprocessor Systems
  • Low-End Endoscopic Reprocessor Systems
• Personal Protective Barriers
• Endoscope Reprocessing Products
• Anti-Microbial Surfaces
• Other Infection Control Products

Application                                                                              

• Surgical Instruments
• Endoscopes
• Ultrasound Probes
• Others

Distribution Channel

• Direct Tender
• Retail Sales
• Third Party Distributors

End User                                 

• Hospitals
• Clinics
• Medical Device Companies
• Pharmaceutical and Biotechnology Companies
• Laboratories
• Others

Infection Control Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, product, application, distribution channel and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America stands at the forefront of the global infection control market, propelled by the proactive initiatives of established industry players. The region's dominance is underscored by a consistent influx of strategic partnerships forged by key market stakeholders. These collaborations not only signify a commitment to innovation and promise to accelerate the growth trajectory of the infection control market in North America throughout the forecast period, solidifying its leading position in the global landscape.

The Asia-Pacific is expected to experience rapid growth in the global infection control market, primarily attributed to the proliferation of outsourcing organizations. This growth trajectory is fueled by heightened healthcare expenditure across the region, which is anticipated to continue driving demand for infection control measures. With an increasing incidence of healthcare-associated infections, there's a growing emphasis on stringent infection prevention protocols, further propelling market expansion in the Asia-Pacific region.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.

Croissance de la base installée des infrastructures de santé et pénétration des nouvelles technologies

Le marché vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les biens d'équipement, la base installée de différents types de produits pour le marché, l'impact de la technologie à l'aide de courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché. Les données sont disponibles pour la période historique 2016-2021.

Analyse du paysage concurrentiel et du marché du contrôle des infections

Le paysage concurrentiel du marché fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises par rapport au marché.

Certains des principaux acteurs opérant sur le marché sont

• 3M (États-Unis)
• STERIS. (États-Unis)
• Getinge AB (Suède)
• GROUPE MATACHANA (Espagne)
• Ecolab (États-Unis)
• BELIMED, INC (Suisse)
• Cardinal Health. (États-Unis)
• Steelco SpA (Italie)
• Reckitt Benckiser Group plc (Royaume-Uni)
• Stryker (États-Unis)
• B. Braun SE (Allemagne)
• Covalon Technologies Ltée (Canada)
• SKYTRON, LLC (États-Unis)
• Olympus Corporation (Japon)
• Groupe COLTENE (Suisse)
• Pal International (Royaume-Uni)
• MELAG Medizintechnik GmbH & Co. KG (Allemagne)
• Terragene (Royaume-Uni)
• La société Clorox (États-Unis)

SKU-3010